Noxopharm Limited (NOX.AX)

AUD 0.09

(-1.06%)

Total Assets Summary of Noxopharm Limited

  • Noxopharm Limited's latest annual total assets in 2024 was 6.78 Million AUD , down -33.02% from previous year.
  • Noxopharm Limited's latest quarterly total assets in 2024 FY was 6.78 Million AUD , down -33.02% from previous quarter.
  • Noxopharm Limited reported annual total assets of 10.12 Million AUD in 2023, down -61.91% from previous year.
  • Noxopharm Limited reported annual total assets of 26.59 Million AUD in 2022, down -44.43% from previous year.
  • Noxopharm Limited reported quarterly total assets of 6.78 Million AUD for 2024 Q4, down 0.0% from previous quarter.
  • Noxopharm Limited reported quarterly total assets of 6.78 Million AUD for 2024 FY, down -33.02% from previous quarter.

Annual Total Assets Chart of Noxopharm Limited (2024 - 2016)

Historical Annual Total Assets of Noxopharm Limited (2024 - 2016)

Year Total Assets Total Assets Growth
2024 6.78 Million AUD -33.02%
2023 10.12 Million AUD -61.91%
2022 26.59 Million AUD -44.43%
2021 47.85 Million AUD 138.47%
2020 20.06 Million AUD 366.63%
2019 4.3 Million AUD -70.44%
2018 14.54 Million AUD 414.37%
2017 2.82 Million AUD -54.43%
2016 6.2 Million AUD 0.0%

Peer Total Assets Comparison of Noxopharm Limited

Name Total Assets Total Assets Difference
EZZ Life Science Holdings Limited 25.55 Million AUD 73.451%
Anatara Lifesciences Ltd 1.67 Million AUD -305.867%
Zelira Therapeutics Limited 5.18 Million AUD -30.874%
Biome Australia Limited 8.27 Million AUD 18.039%
Patrys Limited 4.16 Million AUD -63.009%
Orthocell Limited 26.61 Million AUD 74.512%
Imugene Limited 151.39 Million AUD 95.519%
PYC Therapeutics Limited 91.23 Million AUD 92.565%
Chimeric Therapeutics Limited 15.27 Million AUD 55.584%
Prescient Therapeutics Limited 20.39 Million AUD 66.735%
Proteomics International Laboratories Limited 10.87 Million AUD 37.621%
Cynata Therapeutics Limited 8.38 Million AUD 19.128%
CSL Limited 56.93 Billion AUD 99.988%
Arovella Therapeutics Limited 13.28 Million AUD 48.935%
Bio-Gene Technology Limited 3.15 Million AUD -114.704%
Clinuvel Pharmaceuticals Limited 231.12 Million AUD 97.065%
Starpharma Holdings Limited 36.81 Million AUD 81.573%
Nanollose Limited 241.95 Thousand AUD -2703.773%
Memphasys Limited 12.43 Million AUD 45.425%
Invex Therapeutics Ltd 6.12 Million AUD -10.845%
NeuroScientific Biopharmaceuticals Limited 5.43 Million AUD -24.796%
Amplia Therapeutics Limited 14.84 Million AUD 54.303%
Botanix Pharmaceuticals Limited 112.46 Million AUD 93.968%
Island Pharmaceuticals Limited 2.56 Million AUD -164.529%
Race Oncology Limited 20.22 Million AUD 66.464%
Nyrada Inc. 5.9 Million AUD -14.838%
Telix Pharmaceuticals Limited 398.3 Million AUD 98.297%
Dimerix Limited 32.07 Million AUD 78.853%
PharmAust Limited 11.12 Million AUD 39.022%
Immutep Limited 147.44 Million AUD 95.399%
Clarity Pharmaceuticals Ltd 154.62 Million AUD 95.613%
Alterity Therapeutics Limited 19.22 Million AUD 64.712%
BTC Health Limited 5.14 Million AUD -31.754%
Acrux Limited 8.96 Million AUD 24.314%
Neuren Pharmaceuticals Limited 247.97 Million AUD 97.264%
Biotron Limited 493.47 Thousand AUD -1274.689%
Tissue Repair Ltd 19.38 Million AUD 65.013%
AdAlta Limited 5.57 Million AUD -21.725%
Radiopharm Theranostics Limited 72.03 Million AUD 90.583%
Hexima Limited 2.26 Million AUD -198.975%
AnteoTech Limited 9.38 Million AUD 27.688%
Paradigm Biopharmaceuticals Limited 27.39 Million AUD 75.233%
Recce Pharmaceuticals Ltd 6.36 Million AUD -6.502%
Avecho Biotechnology Limited 7.31 Million AUD 7.317%
Actinogen Medical Limited 21.31 Million AUD 68.169%
Immuron Limited 15.54 Million AUD 56.374%
Argenica Therapeutics Limited 16.37 Million AUD 58.579%